COVID-19-Associated Histoplasmosis in an AIDS Patient

• Published in: Mycopathologia (1975) Vol. 186; no. 1; pp. 109 - 112
• Main Authors: Basso, Rossana Patricia, Poester, Vanice Rodrigues, Benelli, Jéssica Louise, Stevens, David A., Zogbi, Heruza Einsfeld, Vasconcellos, Izadora Clezar da S., Pasqualotto, Alessandro Comarú, Xavier, Melissa Orzechowski
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01-03-2021; Springer; Springer Nature B.V
• Subjects: Acquired immune deficiency syndrome; Acquired Immunodeficiency Syndrome - complications; Acquired Immunodeficiency Syndrome - drug therapy; Adult; AIDS; AIDS-Related Opportunistic Infections - diagnosis; AIDS-Related Opportunistic Infections - drug therapy; AIDS-Related Opportunistic Infections - etiology; Antifungal Agents - therapeutic use; Aspergillosis; Biomedical and Life Sciences; Brazil; Case reports; Coinfection; Coronaviruses; COVID-19; COVID-19 - complications; COVID-19 - microbiology; Eukaryotic Microbiology; Female; Histoplasmosis; Histoplasmosis - diagnosis; Histoplasmosis - drug therapy; Histoplasmosis - etiology; HIV; HIV patients; Human immunodeficiency virus; Humans; Infections; Life Sciences; Medical Microbiology; Microbial Ecology; Microbiology; Plant Sciences; SARS-CoV-2; Short Communication; Treatment Outcome; Brazil; COVID-19; Mycoses; AIDS; SARS-CoV-2; Histoplasma capsulatum
• ISSN: 0301-486X; 1573-0832
• DOI: 10.1007/s11046-020-00505-1

Most reports associating fungal infections with COVID-19 have been cases of invasive aspergillosis. Here, we report a case of severe histoplasmosis and COVID-19 infections in an HIV patient in Rio Grande, Southern Brazil. Histoplasmosis must be included as a diagnostic possibility in opportunistic fungal co-infections in COVID-19 patients with AIDS, mainly in endemic areas.